During the past decade, Bugat Pal Korhaz conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 14 clinical trials were completed, i.e. on average, 37.8% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 11 clinical trials were completed. i.e. 39.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bugat Pal Korhaz" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Pfizer" with 6 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Arena Pharmaceuticals" with 3 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bugat Pal Korhaz" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Centessa Pharmaceuticals plc" with 1 trials as a collaborator, "Dr. Falk Pharma GmbH" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Bugat Pal Korhaz" are "Crohn's Disease" (7 trials), "Depressive Disorder, Major" (7 trials), "Ulcerative Colitis" (7 trials), "Colitis, Ulcerative" (4 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "Bugat Pal Korhaz" in a lesser frequency.

Most popular intervention types in "Bugat Pal Korhaz" are "Drug" (39 trials), "Other" (6 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "Etrasimod" (5 trials), "CP-690,550" (3 trials), "Guselkumab" (3 trials) and "Aticaprant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Bugat Pal Korhaz" are 41 trials for "All" genders.

Currently, there are NaN active trials in "Bugat Pal Korhaz". undefined are not yet recruiting, 10 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Bugat Pal Korhaz, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Bugat Pal Korhaz, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".